Application of Low Intensity Ultrasound in the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is a common neurodegenerative disease in clinical practice. The pathogenesis is still unclear, and there is no specific method. According to the current known pathological studies, AD biomarker TAU protein, phosphorylated tau and amyloid-β (Aβ) play an important role in the...
Saved in:
Main Author: | Hong Fei, Xu Fei |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of Advanced Ultrasound in Diagnosis and Therapy
2025-03-01
|
Series: | Advanced Ultrasound in Diagnosis and Therapy |
Subjects: | |
Online Access: | https://www.journaladvancedultrasound.com/fileup/2576-2516/PDF/1738998944954-44645644.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01) -
The Science of Memory Loss: Insights into Alzheimer’s Disease
by: Agnieszka Starzyk, et al.
Published: (2025-02-01) -
The effect of mild-stage Alzheimer’s disease on the acoustic parameters of voice
by: Emel Arslan-Sarımehmetoğlu, et al.
Published: (2025-02-01) -
Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
by: Hua-xiong Zhang, et al.
Published: (2025-02-01) -
Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease
by: Tian Meng, et al.
Published: (2025-02-01)